The incidence of cytomegalovirus infection after deceased-donor kidney transplantation from hepatitis-C antibody positive donors to hepatitis-C antibody negative recipients

References

• Reese PP, Abt PL, Blumberg EA, et al. Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial. Ann Intern Med. 2018;169(5):273–281.
   PubMed Web of Science ®Google Scholar
• Durand CM, Bowring MG, Brown DM, et al. Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial. Ann Intern Med. 2018;168(8):533–540.
   PubMed Web of Science ®Google Scholar
• Goldberg DS, Abt PL, Blumberg EA, et al. Trial of transplantation of HCV-infected kidneys into uninfected recipients. N Engl J Med. 2017;376(24):2394–2395.
   PubMed Web of Science ®Google Scholar
• Molnar MZ, Nair S, Cseprekal O, et al. Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: single center experience. Am J Transplant. 2019;19(11):3046–3057.
   PubMed Web of Science ®Google Scholar
• Durand CM, Chattergoon MA, Desai NM. Lessons from the real world: HCV-infected donor kidney transplantation as standard practice. Am J Transplant. 2019;19(11):2969–2970.
   PubMed Web of Science ®Google Scholar
• Sise ME, Chute DF, Gustafson JL, et al. Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients. Hemodial Int. 2018;22(1):S71–S80.
   PubMedGoogle Scholar
• Potluri VS, Goldberg DS, Mohan S, et al. National trends in utilization and 1-year outcomes with transplantation of HCV-viremic kidneys. J Am Soc Nephrol. 2019;30(10):1939–1951.
   PubMed Web of Science ®Google Scholar
• Nangia G, Borges K, Reddy KR. Use of HCV-infected organs in solid organ transplantation: an ethical challenge but plausible option. J Viral Hepat. 2019;26(12):1362–1371.
   PubMed Web of Science ®Google Scholar
• La Hoz RM, Sandikci B, Ariyamuthu VK, et al. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals. Am J Transplant. 2019;19(11):3058–3070.
   PubMed Web of Science ®Google Scholar
• Eckman MH, Woodle ES, Thakar CV, et al. Transplanting hepatitis C virus-infected versus uninfected kidneys into hepatitis C virus-infected recipients: a cost-effectiveness analysis. Ann Intern Med. 2018;169(4):214–223.
   PubMed Web of Science ®Google Scholar
• Gupta G, Zhang Y, Carroll NV, et al. Cost-effectiveness of hepatitis C-positive donor kidney transplantation for hepatitis C-negative recipients with concomitant direct-acting antiviral therapy. Am J Transplant. 2018;18(10):2496–2505.
   PubMed Web of Science ®Google Scholar
• Selvey LA, Lim WH, Boan P, et al. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience. BMC Infect Dis. 2017;17(1):501.
   PubMedGoogle Scholar
• Humar A, Lebranchu Y, Vincenti F, et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant. 2010;10(5):1228–1237.
   PubMed Web of Science ®Google Scholar
• Bodro M, Sanclemente G, Crespo G, et al. Severe hepatitis C recurrence as a risk factor for opportunistic infections in liver transplant recipients. Transplant Proc. 2018;50(5):1437–1443.
   PubMed Web of Science ®Google Scholar
• Müller-Durovic B, Grählert J, Devine OP, et al. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging. 2019;11(2):724–740.
   PubMedGoogle Scholar
• Pollmann J, Rölle A, Hofmann M, et al. Hepatitis C virus and human cytomegalovirus-natural killer cell subsets in persistent viral infections. Front Immunol. 2017;8:566.
   PubMed Web of Science ®Google Scholar
• Sagedal S, Hartmann A, Nordal KP, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int. 2004;66(1):329–337.
   PubMed Web of Science ®Google Scholar
• Humar A, Gillingham KJ, Payne WD, et al. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation. 1999;68(12):1879–1883.
   PubMed Web of Science ®Google Scholar
• Leppke S, Leighton T, Zaun D, et al. Scientific registry of transplant recipients: collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev. 2013;27(2):50–56.
   Web of Science ®Google Scholar
• Razonable RR, Burak KW, van Cruijsen H, et al. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis. 2002;35(8):974–981.
   PubMed Web of Science ®Google Scholar
• Bosch W, Heckman MG, Pungpapong S, et al. Association of cytomegalovirus infection and disease with recurrent hepatitis C after liver transplantation. Transplantation. 2012;93(7):723–728.
   PubMed Web of Science ®Google Scholar
• Humar A, Kumar D, Raboud J, et al. Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation. Am J Transplant. 2002;2(5):461–466.
   PubMed Web of Science ®Google Scholar
• Geddawy A, Ibrahim YF, Elbahie NM, et al. Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction. J Transl Int Med. 2017;5(1):8–17.
   PubMed Web of Science ®Google Scholar
• Reese PP, Abt PL, Blumberg EA, et al. Transplanting hepatitis C-positive kidneys. N Engl J Med. 2015;373(4):303–305.
   PubMed Web of Science ®Google Scholar
• Goldberg D, Reese PP. Risks, benefits, and ethical questions associated with transplanting kidneys from hepatitis C virus-infected donors into hepatitis C virus-negative patients. Semin Dial. 2019;32(2):179–186.
   PubMed Web of Science ®Google Scholar
• Yazawa M, Fulop T, Cseprekal O, et al. Incidence of cytomegalovirus infection in deceased donor kidney transplantation from hepatitis-C antibody positive donors to hepatitis-C antibody negative recipients: a national registry analysis. Am J Transplant. 2020;20(S3):826.
   Google Scholar